Trial Profile
Bone Histomorphometry of the Proximal Femur in Denosumab-treated Subjects Undergoing Total Hip Replacement
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Jul 2021
Price :
$35
*
At a glance
- Drugs Denosumab (Primary) ; Demeclocycline; Tetracycline
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Amgen
- 26 Jan 2018 Status changed from active, no longer recruiting to completed.
- 05 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 01 Jun 2017 Planned End Date changed from 1 May 2017 to 1 Feb 2018.